首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
levomilnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-2213
Allergan, Inc.
20080122
LEVOMILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
120
0456-2213_6b214150-47dc-4fd7-bd10-a40aa2188fe7
levomilnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-2221
Allergan, Inc.
20080122
LEVOMILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0456-2221_6b214150-47dc-4fd7-bd10-a40aa2188fe7
levomilnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-2241
Allergan, Inc.
20080122
LEVOMILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
40
0456-2241_6b214150-47dc-4fd7-bd10-a40aa2188fe7
levomilnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-2281
Allergan, Inc.
20080122
LEVOMILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
80
0456-2281_6b214150-47dc-4fd7-bd10-a40aa2188fe7
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2404
Allergan, Inc.
20141230
ASENAPINE MALEATE
DRUG FOR FURTHER PROCESSING
2.5
0456-2404_f893e67e-9a44-4472-b086-68d263775df2
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2407
Allergan, Inc.
20130930
ASENAPINE MALEATE
DRUG FOR FURTHER PROCESSING
5
0456-2407_f893e67e-9a44-4472-b086-68d263775df2
Asenapine Maleate
DRUG FOR FURTHER PROCESSING
0456-2412
Allergan, Inc.
20130930
ASENAPINE MALEATE
DRUG FOR FURTHER PROCESSING
10
0456-2412_f893e67e-9a44-4472-b086-68d263775df2
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3408
Allergan, Inc.
20111031
MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
7
0456-3408_a54f3692-f8c7-4a83-adb6-efe22a98a75e
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3415
Allergan, Inc.
20111031
MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
14
0456-3415_a54f3692-f8c7-4a83-adb6-efe22a98a75e
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3422
Allergan, Inc.
20111031
MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
21
0456-3422_a54f3692-f8c7-4a83-adb6-efe22a98a75e
memantine hydrochloride
DRUG FOR FURTHER PROCESSING
0456-3429
Allergan, Inc.
20111031
MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
28
0456-3429_a54f3692-f8c7-4a83-adb6-efe22a98a75e
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4011
Allergan, Inc.
19980717
CITALOPRAM HYDROBROMIDE
DRUG FOR FURTHER PROCESSING
10
0456-4011_16d1421f-c04b-4af7-bf3a-d22a235e0944
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4021
Allergan, Inc.
19980717
CITALOPRAM HYDROBROMIDE
DRUG FOR FURTHER PROCESSING
20
0456-4021_16d1421f-c04b-4af7-bf3a-d22a235e0944
citalopram hydrobromide
DRUG FOR FURTHER PROCESSING
0456-4041
Allergan, Inc.
19980717
CITALOPRAM HYDROBROMIDE
DRUG FOR FURTHER PROCESSING
40
0456-4041_16d1421f-c04b-4af7-bf3a-d22a235e0944
isavuconazonium sulfate
BULK INGREDIENT
0469-1020
Astellas Pharma US, Inc.
20150306
ISAVUCONAZONIUM SULFATE
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
.54
0469-1020_605279a6-df37-6d7f-e053-2a91aa0a2f70
mirabegron
BULK INGREDIENT
0469-2603
Astellas Pharma US, Inc.
20120628
MIRABEGRON
BULK INGREDIENT
1
0469-2603_fe800fff-f3e8-4939-93ca-7d179b66543e
Phentermine and topiramate
DRUG FOR FURTHER PROCESSING
0480-2299
Teva Pharmaceuticals, Inc.
20241106
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
DRUG FOR FURTHER PROCESSING
11.25; 69
0480-2299_70f0d924-c69c-4734-b781-77fe21d9e869
Tadalafil
DRUG FOR FURTHER PROCESSING
0480-2308
Teva Pharmaceuticals, Inc.
20240524
TADALAFIL
DRUG FOR FURTHER PROCESSING
2.5
0480-2308_5d89ba5e-f9de-44d0-9c72-9f772eae3204
Tadalafil
DRUG FOR FURTHER PROCESSING
0480-2309
Teva Pharmaceuticals, Inc.
20240524
TADALAFIL
DRUG FOR FURTHER PROCESSING
5
0480-2309_5d89ba5e-f9de-44d0-9c72-9f772eae3204
Topiramate
DRUG FOR FURTHER PROCESSING
0480-2356
Teva Pharmaceuticals, Inc.
20230310
TOPIRAMATE
DRUG FOR FURTHER PROCESSING
25
0480-2356_90f5abdf-e78f-4e20-9a94-665c4808924e
首页
(current)
24
(current)
25
(current)
26
(current)
27
(current)
28
(current)
29
(current)
30
(current)
31
(current)
32
(current)
33
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: